Vmn2r86 Activators
Chemical activators of Vmn2r86 include a variety of signaling molecules that engage with specific receptors, triggering a cascade of intracellular events that lead to the protein's activation. Acetylcholine interacts with muscarinic receptors to initiate this process. Upon ligand binding, these receptors activate phospholipase C (PLC), which then catalyzes the formation of inositol trisphosphate (IP3) and diacylglycerol (DAG). This sequence elevates intracellular calcium levels as calcium is released from the endoplasmic reticulum. Concurrently, the rise in DAG and calcium activates protein kinase C (PKC), which can directly or indirectlyChemical activators of Vmn2r86 function through a series of well-coordinated intracellular signaling pathways that converge on the modulation of this protein. When acetylcholine binds to muscarinic receptors, it triggers the activation of phospholipase C (PLC), which in turn leads to the generation of inositol trisphosphate (IP3) and diacylglycerol (DAG). These messengers facilitate the release of calcium from intracellular stores and activate protein kinase C (PKC). PKC, now active, is capable of engaging with Vmn2r86, thereby modulating its activity. Similarly, norepinephrine, by stimulating alpha-1 adrenergic receptors, and serotonin, through its interaction with 5-HT2 receptors, both promote the Gq protein-PLC signaling pathway, which also culminates in the activation of PKC and subsequent modulation of Vmn2r86.
Other chemicals follow a comparable route to influence Vmn2r86. Histamine, after binding to H1 receptors, and glutamate, through its metabotropic receptors, each stimulate the Gq protein-PLC pathway. This leads to the generation of IP3 and DAG and the subsequent activation of PKC. ATP, by engaging with P2Y purinergic receptors, and bradykinin, via its B2 receptor, also act through the Gq protein to activate PLC, thus influencing Vmn2r86 activity via the PKC signaling pathway. Angiotensin II, working through the AT1 receptor, endothelin-1, via the ETA receptor, oxytocin, and thrombin, each via their respective Gq-coupled receptors, activate the same cascade, culminating in the activation of PKC. Once activated, PKC acts as a pivotal player in the regulation of Vmn2r86, although the specific interactions and regulatory mechanisms may vary depending on the chemical and context of activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine binds to H1 receptors, which are coupled to Gq proteins. This interaction activates PLC, leading to the production of IP3 and DAG, thereby increasing intracellular calcium and activating PKC. The PKC activation is part of the cascade that activates Vmn2r86 through phosphorylation or other regulatory mechanisms within the cell. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine, through its action on alpha-1 adrenergic receptors, stimulates the Gq protein-PLC pathway, increasing IP3 and DAG levels, and ultimately raising intracellular calcium concentrations. This activation of PKC can lead to the activation of Vmn2r86 as part of the cellular response to elevated calcium and PKC signaling. | ||||||
L-Glutamic Acid | 56-86-0 | sc-394004 sc-394004A | 10 g 100 g | $297.00 $577.00 | ||
Glutamate, by binding to metabotropic glutamate receptors, can activate the Gq protein-PLC pathway, leading to increased IP3 and DAG. The subsequent rise in intracellular calcium and activation of PKC can lead to the activation of Vmn2r86 as these signaling molecules interact with and modulate the protein's function. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
ATP interacts with P2Y purinergic receptors, which are Gq-coupled and can activate the PLC pathway. This results in the elevation of IP3 and DAG, followed by an increase in intracellular calcium and activation of PKC. PKC, through its downstream effects, can activate Vmn2r86 as it modulates the protein's function within this signaling cascade. | ||||||
Bradykinin | 58-82-2 | sc-507311 | 5 mg | $110.00 | ||
Bradykinin, through its B2 receptor, activates the Gq protein-PLC pathway, leading to the production of IP3 and DAG, with the consequent increase in intracellular calcium and activation of PKC. The activation of PKC then contributes to the activation of Vmn2r86 as part of the cellular signaling processes. | ||||||
Serotonin hydrochloride | 153-98-0 | sc-201146 sc-201146A | 100 mg 1 g | $118.00 $187.00 | 15 | |
Serotonin can activate the Gq protein-PLC pathway via the 5-HT2 receptors, which increases IP3 and DAG levels. The resulting activation of PKC can lead to the activation of Vmn2r86. This occurs as the increased intracellular calcium and PKC activity modulate the protein's function as part of the signaling pathway. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II, through the AT1 receptor, activates the Gq protein-PLC pathway, which increases IP3 and DAG production. This leads to the activation of PKC, which can then activate Vmn2r86 through downstream phosphorylation events or by altering its conformation as part of the cellular response to angiotensin II. | ||||||
Thrombin from human plasma | 9002-04-4 | sc-471713 | 100 U | $235.00 | ||
Thrombin acts through protease-activated receptors (PARs) to activate the Gq protein-PLC pathway, raising IP3 and DAG levels and thereby increasing intracellular calcium and activating PKC. PKC can activate Vmn2r86, as part of the signaling pathway, by phosphorylating it or changing its activity state. | ||||||
Oxytocin acetate salt | 50-56-6 | sc-279938 sc-279938A sc-279938B sc-279938C sc-279938D sc-279938E | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $60.00 $180.00 $337.00 $663.00 $969.00 $1836.00 | 4 | |
Oxytocin binds to its Gq-coupled receptor, leading to the activation of PLC and an increase in IP3 and DAG levels. This induces the release of calcium from intracellular stores and activates PKC, which can then activate Vmn2r86 within the signaling pathway that responds to oxytocin. | ||||||